Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
9.61
+0.11 (1.16%)
Apr 10, 2026, 1:55 PM CST
SHE:300534 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 241.33 | 289.65 | 288.95 | 369.24 | 99.12 |
Cash & Short-Term Investments | 241.33 | 289.65 | 288.95 | 369.24 | 99.12 |
Cash Growth | -16.68% | 0.24% | -21.75% | 272.52% | -16.13% |
Accounts Receivable | 257.51 | 216.67 | 223.8 | 220.95 | 140.44 |
Other Receivables | 11.06 | 19.28 | 19.5 | 19.7 | 5.53 |
Receivables | 268.57 | 235.95 | 243.3 | 240.65 | 145.98 |
Inventory | 115.99 | 115.82 | 97.4 | 85.87 | 55.7 |
Prepaid Expenses | - | 0.03 | 0.16 | 0.2 | 1.4 |
Other Current Assets | 28.41 | 35.05 | 17.19 | 31.57 | 6.51 |
Total Current Assets | 654.3 | 676.5 | 647 | 727.54 | 308.7 |
Property, Plant & Equipment | 531.64 | 514.24 | 439.42 | 333.85 | 305.21 |
Long-Term Investments | 52.75 | 51.36 | 54.2 | 54.2 | 54.2 |
Goodwill | 13.72 | 13.72 | 13.72 | 13.72 | 13.72 |
Other Intangible Assets | 68.65 | 62.81 | 62.07 | 62.22 | 50.74 |
Long-Term Deferred Tax Assets | 14.13 | 11.5 | 10.12 | 8.58 | 5.77 |
Long-Term Deferred Charges | 5.68 | 1.66 | 0.23 | 0.14 | - |
Other Long-Term Assets | 53.62 | 70.51 | 109.89 | 117.25 | 85.73 |
Total Assets | 1,394 | 1,402 | 1,337 | 1,318 | 824.07 |
Accounts Payable | 319.44 | 361.08 | 243.56 | 209.01 | 32.63 |
Accrued Expenses | 8.05 | 27.08 | 23.11 | 58.51 | 6.3 |
Short-Term Debt | 0.25 | - | 30.03 | - | - |
Current Portion of Long-Term Debt | 50.35 | 10.2 | - | - | - |
Current Portion of Leases | - | 1.16 | 1.19 | - | - |
Current Income Taxes Payable | 18.83 | 30.91 | 21.1 | 17.48 | 1.78 |
Current Unearned Revenue | 15.62 | 22.4 | 65.65 | 77.24 | 12.96 |
Other Current Liabilities | 45.2 | 66.52 | 53.7 | 45.08 | 14.64 |
Total Current Liabilities | 457.74 | 519.35 | 438.34 | 407.32 | 68.32 |
Long-Term Debt | 103.35 | 95.84 | 109.6 | - | - |
Long-Term Leases | 2.38 | 2.58 | 3.72 | - | - |
Long-Term Unearned Revenue | 46.9 | 31.33 | 26.44 | 26.89 | 22.92 |
Long-Term Deferred Tax Liabilities | 3.05 | 1.54 | 0.24 | - | 0 |
Other Long-Term Liabilities | - | 23.75 | 46.8 | - | - |
Total Liabilities | 613.42 | 674.39 | 625.14 | 434.21 | 91.24 |
Common Stock | 303.35 | 303.35 | 303.35 | 303.35 | 303.35 |
Additional Paid-In Capital | 97.15 | 83.83 | 66.68 | 324 | 231.49 |
Retained Earnings | 309.01 | 277.35 | 263.68 | 202.03 | 185.42 |
Comprehensive Income & Other | -1.05 | -2.24 | - | - | - |
Total Common Equity | 708.45 | 662.28 | 633.71 | 829.38 | 720.25 |
Minority Interest | 72.62 | 65.64 | 77.8 | 53.92 | 12.59 |
Shareholders' Equity | 781.08 | 727.93 | 711.51 | 883.3 | 732.84 |
Total Liabilities & Equity | 1,394 | 1,402 | 1,337 | 1,318 | 824.07 |
Total Debt | 156.33 | 109.78 | 144.54 | - | - |
Net Cash (Debt) | 85 | 179.88 | 144.4 | 369.24 | 99.12 |
Net Cash Growth | -52.74% | 24.56% | -60.89% | 272.52% | 105.97% |
Net Cash Per Share | 0.28 | 0.59 | 0.48 | 1.22 | 0.33 |
Filing Date Shares Outstanding | 303.19 | 303.35 | 303.35 | 303.35 | 303.35 |
Total Common Shares Outstanding | 303.19 | 303.35 | 303.35 | 303.35 | 303.35 |
Working Capital | 196.56 | 157.15 | 208.65 | 320.22 | 240.38 |
Book Value Per Share | 2.34 | 2.18 | 2.09 | 2.73 | 2.37 |
Tangible Book Value | 626.08 | 585.75 | 557.91 | 753.43 | 655.78 |
Tangible Book Value Per Share | 2.06 | 1.93 | 1.84 | 2.48 | 2.16 |
Buildings | - | 483.38 | 339.21 | 338.42 | 283.91 |
Machinery | - | 198.76 | 148.61 | 125.14 | 66.35 |
Construction In Progress | - | 27.61 | 105.7 | 6.09 | 37.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.